Background Image
Table of Contents Table of Contents
Previous Page  57 / 60 Next Page
Information
Show Menu
Previous Page 57 / 60 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 32, No 1, January/February 2021

AFRICA

55

to Tobacco

.

Geneva, Switzerland: World Health Organization, 2012.

17. Institute for Health Metrics and Evaluation. South Africa: Top 10 risks

contributing to DALYs in 2017 and percent change, 2007–2017, all ages,

number. IMHE Measuring what matters.

[Online] 2017. http://www.

healthdata.org/south-africa.

18. Shisana O, Labadarios D, Rehle T,

et al

. South African National Health

and Nutrition Examination Survey (SANHANES-1)

.

Cape Town:

HSRC Press, 2013.

19. Reddy SP, James S, Sewpaul R,

et al.

Umthente Uhlaba Usamila – the

3rd South African National Youth Risk Behaviour Survey 2011

.

Cape

Town: South African Medical Research Council, 2013.

20. International Diabetes Federation (IDF).

IDF Diabetes Atlas.

9th edn

.

[Online] 2019.

http://www.diabetesatlas.org/en/resources/.html.

21. Rispel LC, Padarath A (eds). South African Health Review 2018.

Durban: Health Systems Trust, 2018.

http://www.hst.org.za/publica-

tions/Pages/SAHR2018.

22. Wollum A, Gabert R, McNellan CR,

et al.

Identifying gaps in the

continuum of care for cardiovascular disease and diabetes in two

communities in South Africa: Baseline findings from the HealthRise

project.

PLoS ONE

2018;

13

(3): e0192603.

23. South African Medical Association. SA Heart Guideline: Diet for

prevention of cardiovascular disease. [Online]

https://www.saheart.org/

cms-home/category/24.

24. Van Zyl-Smit RN, Allwood B, Stickells D,

et al.

South African tobacco

smoking cessation clinical practice guideline.

S Afr Med J

2013;

103

(11):

869–876.

25. Klug E, Raal FJ, Marais AD,

et al.

South African dyslipidaemia

guideline consensus statement: 2018 update A joint statement from

the South African Heart Association (SA Heart) and the Lipid and

Atherosclerosis Society of Southern Africa (LASSA).

S Afr Med J

2018;

108

(Part 2): 973–1000.

26. The Society for Endocrinology, Metabolism and Diabetes of South

Africa Type 2 Diabetes Guidelines Expert Committee. The 2017

SEMDSA guidelines for the management of type 2 diabetes mellitus.

J

Endocrinol Metab Diabetes S Afr

2017;

21

(1)(Suppl 1): S1–S196.

27. Seedat YK, Rayner BL, Veriava Y; Hypertension guideline working

group. South African hypertension practice guideline 2014.

Cardiovasc

J Afr

2014;

25

: 288–294.

28. Hitzeroth J, Mpe M, Klug E,

et al

. 2020 Heart Failure Society of South

Africa perspective on the 2016 European Society of Cardiology Chronic

Heart Failure Guidelines.

S Afr Med J

2020;

110

(9b): 938–951.

29. Zühlke L, Mirabel M, Marijon E. Congenital heart disease and rheu-

matic heart.

Heart

2013;

99

: 1554–1561.

30. National Department of Health.

Standard Treatment Guidelines and

Essential Medicines List for South Africa Primary Healthcare Level.

6th

edn

.

Pretoria: Republic of South Africa, 2018.

31. Karthikeyan G, Zühlke L, Engel M,

et al

. Rationale and design of a

global rheumatic heart disease registry: The REMEDY study.

Am Heart

J

2012;

163

(4): 535–540.

32. Busko M. Valvular atrial fibrillation with HF common, often untreated

in young Africans.

Medscape

07 June 2016.

https://www.medscape.com/

viewarticle/864451.

33. Moodley Naidoo R, Timothy GA, Steenkamp L,

et al.

Measuring qual-

ity outcomes across hospital systems: Using a claims data model for

risk adjustment of mortality rates.

S Afr Med J

2019;

109

(5): 299–305.

34. World Health Organization.

WHO Model List of Essential Medicines

.

20th edn. Essential Medicines and Health Products, 2017. https://www.

who.int/medicines/publications/essentialmedicines/en/.

35. Yusuf S, Islam S, Chow CK,

et al

. Use of secondary prevention drugs

for cardiovascular disease in the community in high-income, middle-

income, and low-income countries (the PURE Study): a prospective

epidemiological survey.

Lancet

2011;

378

(9798): 1231–1243.

36. Zühlke L, Karthikeyan G, Engel ME. Clinical outcomes in 3343

children and adults with rheumatic heart disease from 14 low- and

middle-income countries: two-year follow-up of the global rheumatic

heart disease registry (the REMEDY Study).

Circulation

2016;

134

(19):

1456–1466.

37. Statistics South Africa.

South Africa Demographic and Health Survey

2016: Key Indicator Report.

Pretoria: Statistics South Africa, 2017.

38. Department of Health. Strategic plan for the prevention and control of

non-communicable diseases 2013–17. Pretoria: RSA, 2013.

39. Statistics South Africa. Causes of Death. Mortality and causes of death

report. Stats SA, 2018 (ongoing).

http://www.statssa.gov.za/.

40. Robertson KA, Volmink JA, Mayosi BM, Writing Committee. 1st All

Africa Workshop on Rheumatic Fever and Rheumatic Heart Disease

Champagne Sports Resort, Drakensberg, South Africa, 15–16 October

2005. Towards a uniform plan for the control of rheumatic fever and

rheumatic heart disease in Africa.

S Afr Med J

2006;

96

(3): 241–245.

41. Tobacco Control Research Group, Department for Health at the

University of Bath. South Africa Country Profile.

Tobacco Tactics.

30

April 2020.

https://tobaccotactics.org/wiki/south-africa-country-profile/.

42. Department of Health. Act (12/2012): Draft Control of Tobacco

Products.

Government Gazette

No. 41617

.

Pretoria: Dept of Health, 9

May 2018; 635.

43. World Health Organization. The World Health Organization framework

convention on tobacco control (FCTC). South_Africa_2018_report

.

2018. Available:

http://untobaccocontrol.org/impldb/.

44. International Legal Consortium, Global Legal Center. Tobacco Control

Laws. Legislation by Country, South Africa: Tobacco Control Policies.

Campaign for Tobacco-Free Kids, United States, 18 September 2019.

https://www.tobaccocontrollaws.org/legislation/factsheet/policy_status/

south-africa.

45. Ortegón M, Lim S, Chisholm D,

et al.

Cost effectiveness of strategies

to combat cardiovascular disease, diabetes, and tobacco use in sub-

Saharan Africa and South East Asia: mathematical modelling study.

Br

Med J

2012;

344

: e607.

46. Pestana JA, Steyn K, Leiman A,

et al

. The direct and indirect costs of

cardiovascular disease in South Africa in 1991.

S Afr Med J

1996;

86

:

679–684.

47. Gaziano TA. Economic burden and the cost-effectiveness of treatment

of cardiovascular diseases in Africa.

Heart

2008;

94

: 140–144.

48. Bangalee V, Suleman F. Has the increase in the availability of generic

drugs lowered the price of cardiovascular drugs in South Africa?

Health

SA Gesondheid

2016;

21

: 60–66.

49. Republic of South Africa. National Health Act, 2003 No. 61 of 2003:

National Health Act, 2004.

Government Gazette

2003;

469

(26595). Cape

Town 23 July 2004.

50. Maphumulo WT, Bhengu BR. Challenges of quality improvement in the

healthcare of South Africa post-apartheid: A critical review.

Curationis

2019;

42

(1): a1901.

51. Republic of South Africa. Constitution of the Republic of South Africa,

Government Gazette

2014. Pretoria, South Africa. 1996.

https://www.gov.

za/documents/constitution/constitution-republic-south-africa-1996-1.

52. Stacey N, Summan A, Tugendhaft A,

et al

. Simulating the impact of

excise taxation for disease prevention in low-income and middle-income

countries: an application to South Africa.

Br Med J Glob Health

2018;

3

: e000568.

53. National Department of Health. Primary Care 101 Guideline 2013/14

.

Pretoria: NDoH, 2013/14.

54. Fairall L, Bateman E, Cornick R,

et al

. Innovating to improve primary